← All organizations

Medy-Tox

For profitWebsite ↗

Also known as: Medy-Tox | Medytox Korea

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Feb 7, 2022

Timeline

2000s

Jun 1, 2000
Medy-Tox— Founded

Drugs by trial phase (7 distinct, 38 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (38)

NCT05321979Lead sponsorPhase 3Feb 7, 2022
NCT05217355Lead sponsorPhase 2Dec 28, 2021
NCT05195112Lead sponsorPhase 3Dec 24, 2021
NCT05059587Lead sponsorPhase 3Aug 30, 2021
NCT04281745Lead sponsorPhase 4Oct 17, 2019
NCT04144049Lead sponsorPhase 2Sep 10, 2019
NCT04113941Lead sponsorPhase 3Aug 23, 2019
NCT04143815Lead sponsorPhase 2Apr 14, 2019
NCT04143854Lead sponsorPhase 2Apr 14, 2019
NCT03837561Lead sponsorPhase 3Dec 12, 2018
NCT03760198Lead sponsorPhase 3Aug 31, 2018
NCT03905291Lead sponsorPhase 1Jul 31, 2018
NCT03547141Lead sponsorPhase 1Apr 16, 2018
NCT03452345Lead sponsorPhase 3Mar 31, 2018
NCT03647982Lead sponsorPhase 1Mar 20, 2018

Details

Founded: Seoul, KR Jun 1, 2000
Last known activity: Feb 7, 2022